UY29185A1 - Formas de dosificación oral sólidas que contienen una dosis baja de estradiol - Google Patents
Formas de dosificación oral sólidas que contienen una dosis baja de estradiolInfo
- Publication number
- UY29185A1 UY29185A1 UY29185A UY29185A UY29185A1 UY 29185 A1 UY29185 A1 UY 29185A1 UY 29185 A UY29185 A UY 29185A UY 29185 A UY29185 A UY 29185A UY 29185 A1 UY29185 A1 UY 29185A1
- Authority
- UY
- Uruguay
- Prior art keywords
- dosage forms
- solid oral
- estrodiol
- oral dosage
- forms containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Formas de dosificación oral sólida que contienen una dosis muy baja de estrodiol. Las formas de dosificación se formulan de modo tal que se evita la degradación del estrodiol y se minimiza el contenido de polivinilpirrolidona, al tiempo que aaún se logra una disolución rápida similar del estrodiol. Las formas de dosificación son útiles para prevenir o tratar una condición física en una mujer, provocada por niveles endógenos insuficientes de estrodiol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04078014 | 2004-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29185A1 true UY29185A1 (es) | 2006-05-31 |
Family
ID=34928627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29185A UY29185A1 (es) | 2004-11-02 | 2005-10-31 | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1814526A2 (es) |
JP (1) | JP2008518895A (es) |
KR (1) | KR20070085558A (es) |
CN (1) | CN101094656A (es) |
AR (1) | AR053650A1 (es) |
AU (1) | AU2005300658A1 (es) |
BR (1) | BRPI0517940A (es) |
CA (1) | CA2585095A1 (es) |
CR (1) | CR9112A (es) |
CU (1) | CU20070094A7 (es) |
EA (1) | EA013262B1 (es) |
GT (1) | GT200500315A (es) |
IL (1) | IL182635A0 (es) |
MX (1) | MX2007005281A (es) |
NO (1) | NO20072704L (es) |
PA (1) | PA8651401A1 (es) |
PE (1) | PE20061126A1 (es) |
TW (1) | TW200621312A (es) |
UY (1) | UY29185A1 (es) |
WO (1) | WO2006048261A2 (es) |
ZA (1) | ZA200705012B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8022053B2 (en) | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
KR20080047957A (ko) * | 2006-11-27 | 2008-05-30 | 주식회사 엠디바이오알파 | 고혈압의 치료 및 예방을 위한 약제 조성물 |
DE102009007771B4 (de) | 2009-02-05 | 2012-02-16 | Bayer Schering Pharma Aktiengesellschaft | Bukkales Applikationssystem, 17α-Estradiol enthaltend |
US20130140210A1 (en) | 2010-04-15 | 2013-06-06 | Bayer Intellectual Property Gmbh | Low-dosed solid oral dosage forms for hrt |
BR112012026115B1 (pt) | 2010-04-15 | 2019-12-24 | Bayer Ip Gmbh | forma de dosagem oral sólida, seu uso, e unidade de acondicionamento |
CN112516149B (zh) * | 2020-07-21 | 2023-07-18 | 南方医科大学 | 苯甲酸***或其药物可接受盐在制备抗冠状病毒的药物中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL125071C (es) * | 1963-12-24 | |||
US4755386A (en) * | 1986-01-22 | 1988-07-05 | Schering Corporation | Buccal formulation |
US5073374A (en) * | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
FR2739558B1 (fr) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
US6326366B1 (en) * | 2000-08-22 | 2001-12-04 | Protein Technologies International | Hormone replacement therapy |
JP2004512369A (ja) * | 2000-10-30 | 2004-04-22 | ユニバーシティ・オブ・チューリッヒ | 尿失禁の治療のためのgnrhアナログ |
DK1343508T3 (da) * | 2000-12-15 | 2012-02-27 | Novo Nordisk Femcare Ag | Anvendelse af et østrogen til fremstilling af en sammensætning, der indeholder østrogen, til behandling af atrofisk vaginitis |
FR2823976A1 (fr) * | 2001-04-25 | 2002-10-31 | Theramex | Nouvelle composition hormonale et son utilisation |
US20030018018A1 (en) * | 2001-07-10 | 2003-01-23 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea |
US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
JP2004155779A (ja) * | 2002-10-16 | 2004-06-03 | Taisho Pharmaceut Co Ltd | 更年期症の予防・治療用経口組成物 |
-
2005
- 2005-10-31 GT GT200500315A patent/GT200500315A/es unknown
- 2005-10-31 UY UY29185A patent/UY29185A1/es not_active Application Discontinuation
- 2005-11-01 TW TW094138264A patent/TW200621312A/zh unknown
- 2005-11-01 JP JP2007538360A patent/JP2008518895A/ja active Pending
- 2005-11-01 WO PCT/EP2005/011726 patent/WO2006048261A2/en active Application Filing
- 2005-11-01 AU AU2005300658A patent/AU2005300658A1/en not_active Abandoned
- 2005-11-01 EA EA200700979A patent/EA013262B1/ru not_active IP Right Cessation
- 2005-11-01 BR BRPI0517940-8A patent/BRPI0517940A/pt not_active IP Right Cessation
- 2005-11-01 KR KR1020077012174A patent/KR20070085558A/ko not_active Application Discontinuation
- 2005-11-01 EP EP05800512A patent/EP1814526A2/en not_active Withdrawn
- 2005-11-01 MX MX2007005281A patent/MX2007005281A/es not_active Application Discontinuation
- 2005-11-01 CN CNA200580045694XA patent/CN101094656A/zh active Pending
- 2005-11-01 CA CA002585095A patent/CA2585095A1/en not_active Abandoned
- 2005-11-02 AR ARP050104580A patent/AR053650A1/es unknown
- 2005-11-02 PA PA20058651401A patent/PA8651401A1/es unknown
- 2005-11-02 PE PE2005001279A patent/PE20061126A1/es not_active Application Discontinuation
-
2007
- 2007-04-18 IL IL182635A patent/IL182635A0/en unknown
- 2007-04-30 CU CU20070094A patent/CU20070094A7/es unknown
- 2007-05-09 CR CR9112A patent/CR9112A/es not_active Application Discontinuation
- 2007-05-29 NO NO20072704A patent/NO20072704L/no not_active Application Discontinuation
- 2007-06-01 ZA ZA200705012A patent/ZA200705012B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008518895A (ja) | 2008-06-05 |
CR9112A (es) | 2007-11-23 |
PE20061126A1 (es) | 2006-11-11 |
MX2007005281A (es) | 2008-03-11 |
EA200700979A1 (ru) | 2007-10-26 |
PA8651401A1 (es) | 2006-12-07 |
WO2006048261A2 (en) | 2006-05-11 |
IL182635A0 (en) | 2007-07-24 |
KR20070085558A (ko) | 2007-08-27 |
AR053650A1 (es) | 2007-05-16 |
BRPI0517940A (pt) | 2008-10-21 |
TW200621312A (en) | 2006-07-01 |
CA2585095A1 (en) | 2006-05-11 |
CU20070094A7 (es) | 2009-09-08 |
AU2005300658A1 (en) | 2006-05-11 |
ZA200705012B (en) | 2008-10-29 |
WO2006048261A3 (en) | 2006-09-21 |
GT200500315A (es) | 2006-06-06 |
CN101094656A (zh) | 2007-12-26 |
NO20072704L (no) | 2007-05-29 |
EA013262B1 (ru) | 2010-04-30 |
EP1814526A2 (en) | 2007-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2557988T3 (es) | Método para tratar enfermedades de próstata basado en el suministro local de principios activos | |
ECSP045407A (es) | Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf | |
AR109263A2 (es) | Composición que comprende moxidectina | |
AR077573A2 (es) | Uso de un inhibidor de tnf y composicion farmaceutica que lo comprende | |
UY29185A1 (es) | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol | |
AR068185A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
AR046510A1 (es) | Composicion de un antagonista de vegf y un agente anti-proliferativo | |
ECSP066553A (es) | Formas de administración masticables, no comprimidas dosificadas individualmente. | |
DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
AR055095A1 (es) | Nuevos inhibidores macrociclicos de la replicacion del virus de la hepatitis c | |
ECSP066378A (es) | "un derivado de isoxazolina como un inhibidor contra varias caspasas, un procedimiento para preparar el mismo y una composicion terapeutica para prevenir la inflamacion y la apotosis que comprende el mismo" | |
ECSP066805A (es) | Compuestos silinano como inhibidores de cisteína proteasa | |
UY28862A1 (es) | Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
CU20070203A7 (es) | Composición farmacéutica que comprende una difenilurea sustituida con omega-carboxiarilo para el tratamiento del cáncer | |
PE20070333A1 (es) | Composicion farmaceutica que comprende agomelatina para el tratamiento de transtornos del sueno en pacientes deprimidos | |
UY29274A1 (es) | Composicion farmaceutica para tratar la hipertension, que comprende telmisartano e hidroclorotiazida | |
DE602006016127D1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
UY28154A1 (es) | Composiciones y metodos de cuidado oral | |
AR058298A1 (es) | Composicion veterinaria | |
AR039977A1 (es) | Composicion a base de diclofenac para el tratamiento topico de afecciones de la cavidad orofaringea | |
AR043013A1 (es) | Composicion farmaceutica destinada al tratamiento de la endometriosis | |
AR048355A1 (es) | Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen | |
AR029718A1 (es) | Composicion farmaceutica a base de cocaetileno y su utilizacion para el tratamiento de la dependencia de las substancias psicoactivas | |
AR037981A1 (es) | Uso de meloxicam en combinacion con un agente antiplaquetario para el tratamiento del sindrome coronario agudo y condiciones relacionadas | |
AR057161A1 (es) | Metodos y formas de dosificacion de derivados de benzisoxazol con mejor eficacia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160525 |